A high-level overview of Vertex Pharmaceuticals Incorporated (VRTX) stock. View (VRTX) real-time stock price, chart, news, analysis, analyst reviews and more.

Vertex Pharmaceuticals Inc. Annual cash flow by MarketWatch. View VRTX net cash flow, operating cash flow, operating expenses and cash dividends.

A high-level overview of CRISPR Therapeutics AG (CRSP) stock. View (CRSP) real-time stock price, chart, news, analysis, analyst reviews and more.

This stock is Vertex Pharmaceuticals (VRTX-1.89%), a biotech that's delivered a long track record of growth and profitability thanks to its leadership in the cystic fibrosis (CF) treatment market.

According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $515.04. Vertex Pharmaceuticals stock opened at $445.85 on ...

This stock is Vertex Pharmaceuticals (NASDAQ: VRTX), a biotech that's delivered a long track record of growth and profitability thanks to its leadership in the cystic fibrosis (CF) treatment ...

Vertex Pharmaceuticals (NASDAQ:VRTX), a leading biotechnology company with a market capitalization of $113.7 billion, is navigating a critical juncture as it seeks to expand its therapeutic reach ...

Vertex belongs to the Zacks Medical - Biomedical and Genetics industry. Another stock from the same industry, Agios Pharmaceuticals (AGIO), has gained 17.8% over the past month. More than a month ...